As suggested by the present results, early Aβ42 oligomerization may gradually disrupt proteasome function and thereby lead to reduced clearance of APP fragments, Aβ peptides, tau species, and perhaps other proteins involved in AD-related protein accumulation pathology. This evidence concerns the gene MAPT and Alzheimer disease.